Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ferry Ossendorp

Showing results (151-160 of 159) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 159 results.
Nature Medicine|March 22, 2006
Selective cytotoxic T-lymphocyte targeting of tumor immune escape variantsThorbald van Hall, Elisabeth Z Wolpert, Peter van Veelen, et al.
Chembiochem : a European Journal of Chemical Biology|November 12, 2020
Simplified Monopalmitoyl Toll-like Receptor 2 Ligand Mini-UPam for Self-Adjuvanting Neoantigen-Based Synthetic Cancer VaccinesThomas C van den Ende, Jeroen M M Heuts, Geoffroy P P Gential, et al.
Plos One|February 25, 2011
Improved innate and adaptive immunostimulation by genetically modified HIV-1 protein expressing NYVAC vectorsEsther D Quakkelaar, Anke Redeker, Elias K Haddad, et al.
Molecular Therapy. Oncology|June 16, 2025
Preclinical development and clinical safety assessment of a synthetic peptide conjugate enabling endogenous antibody binding to promote innate receptor engagementErika A K Fletcher, Robert A Cordfunke, Aikaterini Nasi, et al.
Journal for Immunotherapy of Cancer|October 19, 2022
Intradermal vaccination of HPV-16 E6 synthetic peptides conjugated to an optimized Toll-like receptor 2 ligand shows safety and potent T cell immunogenicity in patients with HPV-16 positive (pre-)malignant lesionsFrank M Speetjens, Marij J P Welters, Marije Slingerland, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 11, 2018
A Restricted Role for FcγR in the Regulation of Adaptive ImmunityMarieke F Fransen, Hreinn Benonisson, Wendy W van Maren, et al.
Cell Reports. Medicine|February 16, 2023
OX40 agonism enhances PD-L1 checkpoint blockade by shifting the cytotoxic T cell differentiation spectrumTetje C van der Sluis, Guillaume Beyrend, Esmé T I van der Gracht, et al.
Nature Immunology|December 15, 2010
Antigen processing by nardilysin and thimet oligopeptidase generates cytotoxic T cell epitopesJan H Kessler, Selina Khan, Ulrike Seifert, et al.
Nature Communications|July 8, 2022
A third vaccination with a single T cell epitope confers protection in a murine model of SARS-CoV-2 infectionIris N Pardieck, Tetje C van der Sluis, Esmé T I van der Gracht, et al.
Pageof 16

Showing results (151-160 of 159) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 159 results.
Nature Medicine|March 22, 2006
Selective cytotoxic T-lymphocyte targeting of tumor immune escape variantsThorbald van Hall, Elisabeth Z Wolpert, Peter van Veelen, et al.
Chembiochem : a European Journal of Chemical Biology|November 12, 2020
Simplified Monopalmitoyl Toll-like Receptor 2 Ligand Mini-UPam for Self-Adjuvanting Neoantigen-Based Synthetic Cancer VaccinesThomas C van den Ende, Jeroen M M Heuts, Geoffroy P P Gential, et al.
Plos One|February 25, 2011
Improved innate and adaptive immunostimulation by genetically modified HIV-1 protein expressing NYVAC vectorsEsther D Quakkelaar, Anke Redeker, Elias K Haddad, et al.
Molecular Therapy. Oncology|June 16, 2025
Preclinical development and clinical safety assessment of a synthetic peptide conjugate enabling endogenous antibody binding to promote innate receptor engagementErika A K Fletcher, Robert A Cordfunke, Aikaterini Nasi, et al.
Journal for Immunotherapy of Cancer|October 19, 2022
Intradermal vaccination of HPV-16 E6 synthetic peptides conjugated to an optimized Toll-like receptor 2 ligand shows safety and potent T cell immunogenicity in patients with HPV-16 positive (pre-)malignant lesionsFrank M Speetjens, Marij J P Welters, Marije Slingerland, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 11, 2018
A Restricted Role for FcγR in the Regulation of Adaptive ImmunityMarieke F Fransen, Hreinn Benonisson, Wendy W van Maren, et al.
Cell Reports. Medicine|February 16, 2023
OX40 agonism enhances PD-L1 checkpoint blockade by shifting the cytotoxic T cell differentiation spectrumTetje C van der Sluis, Guillaume Beyrend, Esmé T I van der Gracht, et al.
Nature Immunology|December 15, 2010
Antigen processing by nardilysin and thimet oligopeptidase generates cytotoxic T cell epitopesJan H Kessler, Selina Khan, Ulrike Seifert, et al.
Nature Communications|July 8, 2022
A third vaccination with a single T cell epitope confers protection in a murine model of SARS-CoV-2 infectionIris N Pardieck, Tetje C van der Sluis, Esmé T I van der Gracht, et al.
Pageof 16